= 2.51 Inventors with similar research interests:
Location History:
- New Braunlels, TX (US) (2007)
- Carlsbad, CA (US) (1995 - 2008)
- San Mateo, CA (US) (2002 - 2010)
- Pittsburgh, PA (US) (2007 - 2010)
- New Braunfels, TX (US) (2011 - 2014)
Years Active: 1995-2014
Title: Lex M Cowsert: A Pioneer in Antisense Technology
Introduction:
Lex M Cowsert, a renowned inventor and scientist based in Carlsbad, CA, has made significant contributions to the field of antisense technology. With an impressive portfolio of 145 patents, Cowsert's innovative research and development have paved the way for advancements in treating various diseases and medical conditions. This article explores his latest patents, career highlights, notable collaborations, and the impact of his work in the field of gene expression modulation.
Latest Patents:
Cowsert's recent patents highlight his expertise in modulating gene expression for therapeutic purposes. One notable patent is titled "Modulation of CD40 Expression," which introduces antisense compounds and methods for decreasing CD40 expression. This breakthrough invention has the potential to treat several disease conditions, including hyperproliferative disorders, graft versus host disease (GVHD), asthma, multiple sclerosis (MS), and certain forms of arthritis.
Another significant patent by Cowsert is "Antisense Modulation of PTP1B Expression." This patent discloses compounds and methods for targeting PTP1B, a protein associated with various diseases. The invention presents antisense oligonucleotides to modulate PTP1B expression, opening doors for potential treatments of diseases involving this protein, such as obesity, diabetes, and cancer.
Career Highlights:
Cowsert's career began at Isis Pharmaceuticals, Inc. (now Ionis Pharmaceuticals), an industry-leading biopharmaceutical company focused on developing RNA-targeted therapeutics. During his time at Isis Pharmaceuticals, Cowsert made significant advancements in the field of antisense technology, shaping the landscape of gene expression modulation. He continued his groundbreaking work in antisense research at other leading institutions, making substantial contributions to the field.
Collaborations:
Cowsert has had the privilege of collaborating with brilliant minds in the scientific community. Notably, his work with Brett P Monia and C Frank Bennett has yielded remarkable outcomes in the field of antisense technology. These collaborations have brought together diverse expertise and paved the way for innovative treatment approaches, advancing the prospects of personalized medicine and targeted therapies.
Conclusion:
Lex M Cowsert stands as a prominent figure in the field of antisense technology with an impressive portfolio of 145 patents. Through his groundbreaking inventions and methodologies in gene expression modulation, Cowsert has opened up possibilities for the treatment of various diseases. His contributions have not only propelled advancements in the medical field but also presented opportunities for personalized medicine approaches. Cowsert's relentless pursuit of innovation continues to shape the landscape of gene therapy, offering hope for improved treatments and better patient outcomes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.